Uwe Naumann

Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry

Thomas Berg, Uwe Naumann, Albrecht Stoehr et al. · Alimentary Pharmacology & Therapeutics · 2019 · 73 citations

Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C

Jacob Nattermann, M. Vogel, Hans Dieter Nischalke et al. · The Journal of Infectious Diseases · 2011 · 53 citations · Full text

Only partial improvement in health‐related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real‐world setting—results from the German Hepatitis C‐Registry (DHC‐R)

Valerie Ohlendorf, Arne Schäfer, Stefan Christensen et al. · Journal of Viral Hepatitis · 2021 · 26 citations · Full text

Low Hrqol, Quality Of Life, Life Assessment +25

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry

Heiner Wedemeyer, P. Erren, Uwe Naumann et al. · Liver International · 2021 · 18 citations · Full text

Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA

Benjamin Heidrich, Steffen B. Wiegand, Peter Buggisch et al. · PLoS ONE · 2014 · 15 citations · Full text